Our recent study (Su et al, 2006) provided evidence that the VEGF-C/VEGFR-3 axis enhances cancer cell mobility and invasiveness and contributes to the promotion of cancer cell metastasis in various types of cancer, including lung adenocarcinoma, breast cancer, cervical prostate cancer, and colorectal cancer. Here, FLT4 is linked to lung adenocarcinoma.